Structural and functional dissection of neutralisation differences among SARS-CoV-2 variants using antigenicity prediction and CR3022 binding analysis - Scorecard - MDSpire
Advertisement
Structural and functional dissection of neutralisation differences among SARS-CoV-2 variants using antigenicity prediction and CR3022 binding analysis
Clinical Scorecard: Analysis of Structural and Functional Variations in Neutralization Among SARS-CoV-2 Variants Through Antigenicity Prediction and CR3022 Binding Assessment
At a Glance
Category
Detail
Condition
SARS-CoV-2 Variants
Key Mechanisms
Mutations in spike glycoprotein affecting antigenicity and neutralization sensitivity.
Target Population
Individuals with natural infection, vaccination, and hybrid immunity.
Care Setting
Clinical research evaluating immune responses to SARS-CoV-2 variants.
Key Highlights
Neutralization responses vary across cohorts and variants.
Higher neutralization titres observed in vaccinated individuals.
B.1.617.2 and B.1.1.529 variants show reduced susceptibility to neutralization.
Computational analyses reveal variant-associated differences in antigenicity.
CR3022 binding affinity varies across different SARS-CoV-2 variants.
Guideline-Based Recommendations
Diagnosis
Evaluate neutralization responses using pseudovirus-based assays.
Management
Consider vaccination history and prior infections when assessing immune responses.
Monitoring & Follow-up
Monitor changes in neutralization sensitivity among emerging variants.
Risks
Reduced neutralization by antibodies in certain variants may lead to increased transmission.
Patient & Prescribing Data
Cohorts representing natural infection, vaccination, and hybrid immunity.
CR3022 monoclonal antibody shows variable neutralization activity against SARS-CoV-2 variants.
Clinical Best Practices
Integrate experimental and computational analyses for understanding antibody responses.
Utilize multi-epitope targeting strategies to enhance neutralization efficacy.
